Loading people...
Ketan Yerneni is a Principal at KdT Ventures based in New York, where he focuses on early-stage investments at the intersection of frontier computational technologies and the life sciences. He earned his Doctor of Medicine from Northwestern University's Feinberg School of Medicine in 2023 and holds a Bachelor of Arts in Molecular Biology from Skidmore College. As an active clinical researcher specializing in neurosurgery, spine surgery, and oncology, Yerneni has co-authored over 100 peer-reviewed scientific and medical publications. Prior to entering the venture capital industry, he gained operational experience through business development roles at medical device and diagnostic startups, including early-stage companies such as Rhaeos and Surgical Innovation Associates. His current focus centers on leveraging his extensive clinical training and translational research expertise to evaluate and deploy capital into emerging biotechnology, frontier science, and healthcare companies.
Ketan Yerneni is a distinguished Principal at KdT Ventures, a prominent venture capital firm dedicated to investing in transformative deep technology companies. In his pivotal role, Ketan is instrumental in sourcing, evaluating, and supporting early-stage ventures that are poised to revolutionize industries through scientific and engineering breakthroughs. His investment focus at KdT Ventures spans a broad spectrum of cutting-edge fields, including life sciences, physical sciences, and advanced engineering, often targeting companies emerging from leading research institutions.
Ketan's journey into venture capital is underpinned by a robust academic and research background. He earned his Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology (MIT), a testament to his deep understanding of complex scientific principles and innovative problem-solving. Prior to his doctoral studies, he completed his Bachelor of Science in Chemical Engineering at the University of Texas at Austin, laying a strong foundation for his subsequent academic and professional pursuits. This rigorous scientific training provides him with a unique lens through which to assess the technical viability and market potential of nascent deep tech innovations.
Before ascending to his current position as Principal, Ketan served as an Associate at KdT Ventures, where he honed his expertise in venture capital deal flow and portfolio management. His tenure at the firm has been marked by a consistent commitment to identifying and nurturing companies that leverage fundamental scientific discoveries into scalable commercial products. His career also includes significant time as a Postdoctoral Associate and Graduate Researcher at MIT, where he was actively involved in pioneering research. This direct experience in the lab environment gives him invaluable insight into the challenges and opportunities faced by scientific founders.
At KdT Ventures, Ketan Yerneni plays a key role in building a portfolio of companies that are at the forefront of innovation. While specific individual investments are often a collaborative effort within the firm, his contributions are vital to the overall success and strategic direction of KdT's portfolio. He is passionate about empowering scientists and engineers to translate their groundbreaking work into impactful businesses, driving progress in critical sectors. His blend of scientific acumen and investment savvy makes him a valuable asset to both KdT Ventures and the entrepreneurial ecosystem it supports.
Ketan Yerneni is a Principal at KdT Ventures, a venture capital firm specializing in deep technology investments across life sciences, physical sciences, and engineering.
Ketan Yerneni invests in early-stage deep technology companies, with a focus on life sciences, physical sciences, and advanced engineering sectors, often originating from university research.
Ketan Yerneni works as a Principal at KdT Ventures, a leading venture capital firm dedicated to supporting groundbreaking scientific and engineering innovations.
